Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Assets (2019 - 2025)

Historic Return on Assets for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to 0.3%.

  • Neurogene's Return on Assets rose 1100.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 0.27% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Neurogene's Return on Assets stood at 0.3%, which was up 1100.0% from 0.28% recorded in Q2 2025.
  • Neurogene's Return on Assets' 5-year high stood at 0.08% during Q1 2023, with a 5-year trough of 0.42% in Q3 2023.
  • Its 3-year average for Return on Assets is 0.29%, with a median of 0.3% in 2025.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -2000bps in 2024, then surged by 1100bps in 2025.
  • Quarter analysis of 3 years shows Neurogene's Return on Assets stood at 0.34% in 2023, then increased by 10bps to 0.3% in 2024, then rose by 2bps to 0.3% in 2025.
  • Its Return on Assets stands at 0.3% for Q3 2025, versus 0.28% for Q2 2025 and 0.25% for Q1 2025.